Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLESONIDE Cause Neurological symptom? 134 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Neurological symptom have been filed in association with CICLESONIDE (Alvesco). This represents 2.3% of all adverse event reports for CICLESONIDE.

134
Reports of Neurological symptom with CICLESONIDE
2.3%
of all CICLESONIDE reports
47
Deaths
131
Hospitalizations

How Dangerous Is Neurological symptom From CICLESONIDE?

Of the 134 reports, 47 (35.1%) resulted in death, 131 (97.8%) required hospitalization, and 116 (86.6%) were considered life-threatening.

Is Neurological symptom Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLESONIDE. However, 134 reports have been filed with the FAERS database.

What Other Side Effects Does CICLESONIDE Cause?

Asthma (4,026) Dyspnoea (2,953) Wheezing (2,785) Therapeutic product effect incomplete (2,337) Loss of personal independence in daily activities (1,575) Obstructive airways disorder (1,403) Cough (1,395) Sleep disorder due to a general medical condition (1,333) Full blood count abnormal (916) Productive cough (847)

What Other Drugs Cause Neurological symptom?

PREDNISONE (307) METFORMIN (240) ALBUTEROL (219) LEVOFLOXACIN (217) AZATHIOPRINE (206) CALCIUM (198) BUDESONIDE (197) METHOTREXATE (195) FUROSEMIDE (188) MAGNESIUM (187)

Which CICLESONIDE Alternatives Have Lower Neurological symptom Risk?

CICLESONIDE vs CICLOPIROX CICLESONIDE vs CICLOPIROX OLAMINE CICLESONIDE vs CICLOSPORIN CICLESONIDE vs CIDOFOVIR CICLESONIDE vs CILASTATIN

Related Pages

CICLESONIDE Full Profile All Neurological symptom Reports All Drugs Causing Neurological symptom CICLESONIDE Demographics